| Nome |
# |
|
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications, file e0ff0074-2c06-9bac-e053-1705fe0af019
|
766
|
|
The G Protein-Coupled Receptor GPR17: Overview and Update, file e0ff0072-b0e8-9bac-e053-1705fe0af019
|
451
|
|
GPR17 receptor modulators and their therapeutic implications: review of recent patents, file e0ff0074-a9fe-9bac-e053-1705fe0af019
|
377
|
|
Overview on Radiolabel-Free in Vitro Assays for GPCRs, file e0ff0072-ac8f-9bac-e053-1705fe0af019
|
300
|
|
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor, file e0ff0072-b2fb-9bac-e053-1705fe0af019
|
210
|
|
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity, file e0ff0073-b0d5-9bac-e053-1705fe0af019
|
188
|
|
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain, file e0ff0073-e005-9bac-e053-1705fe0af019
|
186
|
|
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells, file e0ff0073-c789-9bac-e053-1705fe0af019
|
180
|
|
New sensible method to quantize the intestinal absorption of receptor ligands, file e0ff0073-da40-9bac-e053-1705fe0af019
|
180
|
|
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia, file e0ff0074-474a-9bac-e053-1705fe0af019
|
107
|
|
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site, file e0ff0072-efd7-9bac-e053-1705fe0af019
|
106
|
|
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview, file e0ff0073-f268-9bac-e053-1705fe0af019
|
96
|
|
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists, file e0ff0074-415d-9bac-e053-1705fe0af019
|
90
|
|
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists, file e0ff0074-415e-9bac-e053-1705fe0af019
|
70
|
|
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents, file e0ff0073-9499-9bac-e053-1705fe0af019
|
63
|
|
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity, file e0ff0073-0c0b-9bac-e053-1705fe0af019
|
27
|
|
Butter oil (ghee) enrichment with aromatic plants: Chemical characterization and effects on fibroblast migration in an in-vitro wound healing model, file 4db3e2f3-5c8c-4e9b-9cac-938b858a98fe
|
24
|
|
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents, file e0ff0073-0fb8-9bac-e053-1705fe0af019
|
16
|
|
Pharmacological characterization of the GPR17 receptor dual profile, file e0ff0073-08ed-9bac-e053-1705fe0af019
|
14
|
|
Design and synthesis of novel thiazolo[5,4-d]pyrimidine derivatives with high affinity for both the adenosine a1 and a2a receptors, and efficacy in animal models of depression, file e0ff0074-dcba-9bac-e053-1705fe0af019
|
13
|
|
The possible role of the nucleoside adenosine in countering skin aging: A review, file cfcc4eb8-e3df-4b46-a4d1-6059b24dc440
|
6
|
|
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?, file e0ff0074-fba5-9bac-e053-1705fe0af019
|
6
|
|
A patent review of adenosine A2B receptor antagonists (2016-present), file 98ec94e8-7aff-4f03-aee8-17e3f5b17930
|
5
|
|
Discovery of first-in-class multi-target adenosine A2A receptor antagonists-carbonic anhydrase IX and XII inhibitors. 8-Amino-6-aryl-2-phenyl-1,2,4-triazolo [4,3-a]pyrazin-3-one derivatives as new potential antitumor agents, file e0ff0074-9934-9bac-e053-1705fe0af019
|
5
|
|
Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists, file e0ff0074-9ad4-9bac-e053-1705fe0af019
|
5
|
|
Combined therapy of A1AR agonists and A2AAR antagonists in neuroinflammation, file e0ff0074-e319-9bac-e053-1705fe0af019
|
5
|
|
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease, file e0ff0074-e372-9bac-e053-1705fe0af019
|
5
|
|
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis, file e0ff0074-9ad2-9bac-e053-1705fe0af019
|
4
|
|
P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications, file e0ff0074-e31b-9bac-e053-1705fe0af019
|
4
|
|
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction, file e0ff0072-5f55-9bac-e053-1705fe0af019
|
3
|
|
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines, file e0ff0072-8f11-9bac-e053-1705fe0af019
|
3
|
|
Anticancer activity study of A3 adenosine receptor agonists, file e0ff0073-d80d-9bac-e053-1705fe0af019
|
3
|
|
Chemical characterization and in vitro wound healing activity of Tunisian ghee products, file 0b45c680-f8d1-4b74-97bc-e8f64a835d3b
|
2
|
|
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists, file e0ff0072-61d5-9bac-e053-1705fe0af019
|
2
|
|
Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor, file e0ff0072-a9e0-9bac-e053-1705fe0af019
|
2
|
|
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor, file e0ff0072-aa02-9bac-e053-1705fe0af019
|
2
|
|
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype, file e0ff0072-e61e-9bac-e053-1705fe0af019
|
2
|
|
New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases, file e0ff0073-1500-9bac-e053-1705fe0af019
|
2
|
|
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications., file e0ff0073-ba66-9bac-e053-1705fe0af019
|
2
|
|
New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists, file 01f81285-1ef8-481b-9028-31f31ab25c15
|
1
|
|
Discovery of first-in-class multi-target adenosine A2A receptor antagonists-carbonic anhydrase IX and XII inhibitors. 8-Amino-6-aryl-2-phenyl-1,2,4-triazolo [4,3-a]pyrazin-3-one derivatives as new potential antitumor agents, file 57cabbe3-043c-48bd-916a-f8e98fcb4a14
|
1
|
|
Molecular modeling study on potent and selective adenosine A3 receptor agonists., file e0ff0072-4db4-9bac-e053-1705fe0af019
|
1
|
|
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds, file e0ff0072-4e6c-9bac-e053-1705fe0af019
|
1
|
|
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists, file e0ff0072-61d6-9bac-e053-1705fe0af019
|
1
|
|
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine, file e0ff0072-b6e7-9bac-e053-1705fe0af019
|
1
|
|
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA, file e0ff0073-14fe-9bac-e053-1705fe0af019
|
1
|
|
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor, file e0ff0073-8dda-9bac-e053-1705fe0af019
|
1
|
|
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice, file e0ff0074-5c4a-9bac-e053-1705fe0af019
|
1
|
|
New A2A adenosine receptor antagonists: a structure-based upside-down interaction in the receptor cavity, file e0ff0074-a47d-9bac-e053-1705fe0af019
|
1
|
|
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity, file e0ff0074-dcbe-9bac-e053-1705fe0af019
|
1
|
|
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain, file e0ff0075-191e-9bac-e053-1705fe0af019
|
1
|
| Totale |
3.544 |